The Babraham Investor Conference (BIC) is back to bring together like-minded investors focused on early-stage and scale-up life science and med-tech opportunities. Now, companies seeking funding of between £250K to £20M have the opportunity to pitch to an audience of potential investors on 15 May at the Babraham Research Campus, Cambridge.
Apply to present at the 2019 Babraham Investor Conference
Presenting slots are 15 minutes each, including Q&A. There is also ample time for networking in-between sessions and the opportunity to have an exhibition stand.
“This is a unique opportunity for entrepreneurs wanting financial support to start-up or scale-up a life science or med-tech company,” said Derek Jones, CEO, Babraham Research Campus (pictured). “Presenters at BIC will have the opportunity to pitch to a room full of potential investors and other entrepreneurs, which could be game-changing for them and their science. I would encourage those considering applying to present, to do so as soon as possible.”
To apply to present, applicants need to email email@example.com and they will receive a non-confidential investment profile to complete. All applications are reviewed by BIC's screening panel and successful companies will be contacted via email.
There is no charge to apply, however, there is a fee of £100+VAT from each company successful in securing a slot to present. Applications close 5th April 2019.
BIC 2019 strives to present a broad spectrum of investment opportunities with sessions focused on scale-up and venture-stage growth companies, those beyond start-up and those which are in or entering the growth stage of their development.
For further information visit: https://www.babraham.com/bic-2019/
Babraham Bioscience Technologies Ltd (BBT) is responsible for the commercial development of the Babraham Research Campus. The Babraham Research Campus is distinct in its co-location of bioscience companies with the Babraham Institute, a world-renowned research organisation. The Campus provides companies laboratory and office space together with access to outstanding scientific facilities in an ideal geographical location at the core of the Cambridge cluster.